Cleared Traditional

K991582 - CHIRON DIAGNOSTICS ACS: 180 FOLATE

K991582 is the FDA 510(k) clearance for CHIRON DIAGNOSTICS ACS: 180 FOLATE by Chiron Diagnostics Corp.. It is a Class 2 Immunology device (product code CGN) cleared through the Traditional 510(k) pathway after a 54-day FDA review.

K991582 · Chiron Diagnostics Corp. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1999
Decision
54d
Days
Class 2
Risk

K991582 is an FDA 510(k) clearance for the CHIRON DIAGNOSTICS ACS: 180 FOLATE. Classified as Acid, Folic, Radioimmunoassay (product code CGN), Class II - Special Controls.

Submitted by Chiron Diagnostics Corp. (Medfield, US). The FDA issued a Cleared decision on June 30, 1999 after a review of 54 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 862.1295 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Chiron Diagnostics Corp. devices

Submission Details

510(k) Number K991582 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 07, 1999
Decision Date June 30, 1999
Days to Decision 54 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
50d faster than avg
Panel avg: 104d · This submission: 54d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CGN Acid, Folic, Radioimmunoassay
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1295
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - CGN Acid, Folic, Radioimmunoassay

All 51
Devices cleared under the same product code (CGN) and FDA review panel - the closest regulatory comparables to K991582.
VITROS IMMUNODIAGNOSTIC PRODUCTS FOLATE REAGENT PACK 1/2, VITAMIN B12/FOLATE REAGENT PACK 3, PRODUCTS RED CELL FOLATE PA
K001266 · Ortho-Clinical Diagnostics, Inc. · May 2000
IMMULITE 2000 FOLIC ACID, MODEL L2KF02, L2KF06
K993254 · Diagnostic Products Corp. · Nov 1999
AIA-PACK FOLATE ASSAY
K992365 · Tosoh Medics, Inc. · Aug 1999
VITROS IMMUNODIAGNOSTIC PRODUCTS FOLATE REAGENT PACK 1/2, VITROS IMMUNODIAGNOSTIC PRODUCTS VITAMIN B12/FOLATE REAGENT P3
K984166 · Ortho-Clinical Diagnostics, Inc. · Feb 1999
ABBOTT ARCHITECT FOLATE
K984301 · Abbott Laboratories · Feb 1999
ABBOTT AXSYM FOLATE
K972232 · Abbott Laboratories · Jun 1997